United States · FDA National Drug Code directory
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-209_59017833-74a7-4af8-b04d-6128c57b46be
- Product NDC
- 69097-209
- Form
- TABLET, FILM COATED
- Composition / generic term
- EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210330
- Source listing expiry
- 20261231
Source-listed ingredients
- EMTRICITABINE — 200 mg/1
- TENOFOVIR DISOPROXIL FUMARATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-209-02) · 69097-209-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →